We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Bioniche Gets FDA Warning Letter on Sotradecol Promotions
Bioniche Gets FDA Warning Letter on Sotradecol Promotions
September 29, 2009
Bioniche Pharma has received a warning letter from the FDA’s Division of Drug Marketing, Advertising and Communications (DDMAC) for a series of websites promoting its varicose vein treatment Sotradecol.